Last updated at 15 Aug 2024 09:19 PM
Director
DIN: 07949563
Vishal Palabhai Rudach is currently associated with 3 companies as Director. They serve as a Director at JDB PHARMACEUTICAL PROJECT PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07949563.Vishal Palabhai Rudach has previously been associated with 1 company in roles such as Additional Director.Vishal Palabhai Rudach is currently involved in 1 different role. Their most recent position is with AQUALAND INFRAPROJECTS PRIVATE LIMITED as a Director. The first company Vishal Palabhai Rudach was appointed to as a director was JDB PHARMACEUTICAL PROJECT PRIVATE LIMITED. Vishal Palabhai Rudach has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Vishal Palabhai Rudach is currently associated with 3 companies as Director. They serve as a Director at JDB PHARMACEUTICAL PROJECT PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07949563.Vishal Palabhai Rudach has previously been associated with 1 company in roles such as Additional Director.Vishal Palabhai Rudach is currently involved in 1 different role. Their most recent position is with AQUALAND INFRAPROJECTS PRIVATE LIMITED as a Director. The first company Vishal Palabhai Rudach was appointed to as a director was JDB PHARMACEUTICAL PROJECT PRIVATE LIMITED. Vishal Palabhai Rudach has a status of Deactivated. Please verify the details for any specific requirements or conditions.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (1)
1y 8m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| JDB PHARMACEUTICAL PROJECT PRIVATE LIMITED | Director | 12-Mar-2018 |
| ORANGE METACAST PRIVATE LIMITED | Director | 30-Sep-2018 |
| AQUALAND INFRAPROJECTS PRIVATE LIMITED | Director | 06-Nov-2020 |